Arvind Remedies posts 67 per cent growth in net profit for Q3FY13-14 over Q3FY12-13

By On Feb 18, 2014

Arvind Remedies has announced its financial results for the third quarter and nine months ended December 31, 2013. Net Sales for Q3FY13-14 has gone up to Rs 233 crores in comparison to 180 crores of Q3FY12-13 ( an increase of 29 per cent). EBIDTA for Q3FY13-14 shot up to Rs 46 crores as compared to Rs 35 crores in Q3FY12-13. PAT for Q3FY13-14 has increased to Rs19 crores as against Rs 13 crores in Q3FY12-13.

The net sales for 9MFY13-14 has gone up to Rs 636 crores in comparison to Rs 489 crores of 9MFY12-13 (an increase of 30 per cent). EBIDTA for 9MFY13-14 shot up to Rs 124 crores as compared to Rs 95 crores in 9MFY12-13. PAT for 9MFY13-14 has been increased to Rs 48 crores as against Rs 28 crores in 9MFY12-13.

Dr Arvind Shah, Manging Director and Chief Executive Officer, Arvind Remedies said, “We are quite happy with our performance in the third quarter. Our branded retail business is growing fast, while our gynaec, GP and paediatric segments have shown considerable growth during the third quarter.”

EP News Bureau– Mumbai